Holen Sie sich die Stockscreener-App
21.19
3.37%
-0.74
Vorhandelsmarkt:
21.54
0.35
+1.65%
Finanzdaten der Structure Therapeutics Inc Adr-Aktie (GPCR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
32.73%
118.63
|
89.38 | -23.99 | 73.79 | 70.45 |
| Operating Income/Loss |
32.73%
-118.63
|
-89.38 | 23.99 | -73.79 | -70.45 |
| Income/Loss From Continuing Operations Before Tax |
39.78%
-105.92
|
-75.78 | 33.17 | -65.60 | -61.52 |
| Income Tax Expense/Benefit |
23.16%
0.234
|
0.19 | 0.17 | 0.108 | 0.139 |
| Net Income/Loss |
39.74%
-106.16
|
-75.97 | 33.00 | -65.71 | -61.66 |
| Basic Average Shares |
0.29%
217.96
|
217.33 | 4.194 | 175.47 | 172.65 |
| Diluted Average Shares |
0.29%
217.96
|
217.33 | 4.194 | 175.47 | 0.30 |
| Basic Earnings Per Share |
40.00%
-0.49
|
-0.35 | 0.20 | -0.37 | -0.36 |
| Diluted Earnings Per Share |
40.00%
-0.49
|
-0.35 | 0.20 | -0.37 | -0.36 |
0.58%
1.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):